Search by Drug Name or NDC

    NDC 11673-0629-10 Benzethonium chloride Plus Dyclonine hydrochloride .2; .75 mg/10mL; mg/10mL Details

    Benzethonium chloride Plus Dyclonine hydrochloride .2; .75 mg/10mL; mg/10mL

    Benzethonium chloride Plus Dyclonine hydrochloride is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE.

    Product Information

    NDC 11673-0629
    Product ID 11673-629_f31e5472-7f89-0f42-e053-2995a90a19b3
    Associated GPIs 46991002770320
    GCN Sequence Number 048044
    GCN Sequence Number Description sennosides/docusate sodium TABLET 8.6MG-50MG ORAL
    HIC3 D6S
    HIC3 Description LAXATIVES AND CATHARTICS
    GCN 13483
    HICL Sequence Number 021772
    HICL Sequence Number Description SENNOSIDES/DOCUSATE SODIUM
    Brand/Generic Generic
    Proprietary Name Benzethonium chloride Plus Dyclonine hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Liquid Bandage
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route TOPICAL
    Active Ingredient Strength .2; .75
    Active Ingredient Units mg/10mL; mg/10mL
    Substance Name BENZETHONIUM CHLORIDE; DYCLONINE HYDROCHLORIDE
    Labeler Name Target Corporation
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part333A
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0629-10 (11673062910)

    NDC Package Code 11673-629-10
    Billing NDC 11673062910
    Package 10 mL in 1 BOTTLE, WITH APPLICATOR (11673-629-10)
    Marketing Start Date 2017-12-01
    NDC Exclude Flag N
    Pricing Information N/A